Jill Stefanelli
Direktor/Vorstandsmitglied bei NAVIDEA BIOPHARMACEUTICALS, INC.
Vermögen: - $ am 31.05.2024
Profil
Jill Bieker Stefanelli is an Independent Director at Navidea Biopharmaceuticals, Inc. since 2023.
Previously, she was the President, Director & Chief Business Officer at Paige.
Ai, Inc. She obtained her undergraduate, graduate, and doctorate degrees from Kansas State University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 16.11.2023 | 941 667 ( 0,94% ) | - $ | 31.05.2024 |
Aktive Positionen von Jill Stefanelli
| Unternehmen | Position | Beginn |
|---|---|---|
| NAVIDEA BIOPHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.06.2023 |
Ehemalige bekannte Positionen von Jill Stefanelli
| Unternehmen | Position | Ende |
|---|---|---|
Paige.Ai, Inc.
 Paige.Ai, Inc. Miscellaneous Commercial ServicesCommercial Services Paige Ai, Inc. engages in revolutionizing pathology and strengthen lynchpin of medical diagnostics with quantitative, computational technology, fusing machine learning, and human expertise. It involves in building an artificial intelligence to change clinical diagnosis and treatment of cancer. The company is headquartered in New York, NY. | Präsident | - |
Ausbildung von Jill Stefanelli
| Kansas State University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NAVIDEA BIOPHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Paige.Ai, Inc.
Paige.Ai, Inc. Miscellaneous Commercial ServicesCommercial Services Paige Ai, Inc. engages in revolutionizing pathology and strengthen lynchpin of medical diagnostics with quantitative, computational technology, fusing machine learning, and human expertise. It involves in building an artificial intelligence to change clinical diagnosis and treatment of cancer. The company is headquartered in New York, NY. | Commercial Services |
